000 | 01710 a2200457 4500 | ||
---|---|---|---|
005 | 20250514161832.0 | ||
264 | 0 | _c20040506 | |
008 | 200405s 0 0 chi d | ||
022 | _a1003-0603 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYao, Yong-ming | |
245 | 0 | 0 |
_a[Changes in Toll-like receptor 2 and 4 gene expression in vital organs in septic rats and their regulation mechanisms]. _h[electronic resource] |
260 |
_bZhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue _cNov 2003 |
||
300 |
_a646-50 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aAntimicrobial Cationic Peptides |
650 | 0 | 4 |
_aBlood Proteins _xtherapeutic use |
650 | 0 | 4 | _aGene Expression Regulation |
650 | 0 | 4 |
_aInterleukin-10 _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMembrane Glycoproteins _xgenetics |
650 | 0 | 4 | _aMembrane Proteins |
650 | 0 | 4 |
_aRNA, Messenger _xanalysis |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aReceptors, Cell Surface _xgenetics |
650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
650 | 0 | 4 |
_aSepsis _xdrug therapy |
650 | 0 | 4 | _aToll-Like Receptor 2 |
650 | 0 | 4 | _aToll-Like Receptor 4 |
650 | 0 | 4 | _aToll-Like Receptors |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xanalysis |
700 | 1 | _aYan, Xiao-jian | |
700 | 1 | _aYao, Feng-hua | |
700 | 1 | _aCheng, Ming-hua | |
700 | 1 | _aDong, Ning | |
700 | 1 | _aYu, Yan | |
700 | 1 | _aSheng, Zhi-yong | |
773 | 0 |
_tZhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue _gvol. 15 _gno. 11 _gp. 646-50 |
|
999 |
_c14342158 _d14342158 |